• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米颗粒应用的抗流感策略

Anti-Influenza Strategies Based on Nanoparticle Applications.

作者信息

Wieczorek Klaudia, Szutkowska Barbara, Kierzek Elzbieta

机构信息

Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.

NanoBioMedical Centre, Adam Mickiewicz University, 61-704 Poznan, Poland.

出版信息

Pathogens. 2020 Dec 3;9(12):1020. doi: 10.3390/pathogens9121020.

DOI:10.3390/pathogens9121020
PMID:33287259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7761763/
Abstract

Influenza virus has the potential for being one of the deadliest viruses, as we know from the pandemic's history. The influenza virus, with a constantly mutating genome, is becoming resistant to existing antiviral drugs and vaccines. For that reason, there is an urgent need for developing new therapeutics and therapies. Despite the fact that a new generation of universal vaccines or anti-influenza drugs are being developed, the perfect remedy has still not been found. In this review, various strategies for using nanoparticles (NPs) to defeat influenza virus infections are presented. Several categories of NP applications are highlighted: NPs as immuno-inducing vaccines, NPs used in gene silencing approaches, bare NPs influencing influenza virus life cycle and the use of NPs for drug delivery. This rapidly growing field of anti-influenza methods based on nanotechnology is very promising. Although profound research must be conducted to fully understand and control the potential side effects of the new generation of antivirals, the presented and discussed studies show that nanotechnology methods can effectively induce the immune responses or inhibit influenza virus activity both in vitro and in vivo. Moreover, with its variety of modification possibilities, nanotechnology has great potential for applications and may be helpful not only in anti-influenza but also in the general antiviral approaches.

摘要

从大流行的历史中我们知道,流感病毒有可能成为最致命的病毒之一。流感病毒的基因组不断变异,正在对现有的抗病毒药物和疫苗产生耐药性。因此,迫切需要开发新的治疗方法。尽管新一代通用疫苗或抗流感药物正在研发中,但仍未找到完美的解决方案。在这篇综述中,介绍了使用纳米颗粒(NPs)对抗流感病毒感染的各种策略。重点介绍了几类纳米颗粒的应用:作为免疫诱导疫苗的纳米颗粒、用于基因沉默方法的纳米颗粒、影响流感病毒生命周期的裸纳米颗粒以及用于药物递送的纳米颗粒。这个基于纳米技术的抗流感方法快速发展的领域非常有前景。尽管必须进行深入研究以充分理解和控制新一代抗病毒药物的潜在副作用,但已发表和讨论的研究表明,纳米技术方法在体外和体内都能有效诱导免疫反应或抑制流感病毒活性。此外,由于其具有多种修饰可能性,纳米技术具有巨大的应用潜力,不仅可能有助于抗流感,还可能有助于一般的抗病毒方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/be1527182c3d/pathogens-09-01020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/a7e776a100bb/pathogens-09-01020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/afdf276388c6/pathogens-09-01020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/445b64301a14/pathogens-09-01020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/be1527182c3d/pathogens-09-01020-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/a7e776a100bb/pathogens-09-01020-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/afdf276388c6/pathogens-09-01020-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/445b64301a14/pathogens-09-01020-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/099a/7761763/be1527182c3d/pathogens-09-01020-g004.jpg

相似文献

1
Anti-Influenza Strategies Based on Nanoparticle Applications.基于纳米颗粒应用的抗流感策略
Pathogens. 2020 Dec 3;9(12):1020. doi: 10.3390/pathogens9121020.
2
Development of an adjuvanted nanoparticle vaccine against influenza virus, an in vitro study.抗流感病毒佐剂纳米颗粒疫苗的研制:体外研究。
PLoS One. 2020 Aug 6;15(8):e0237218. doi: 10.1371/journal.pone.0237218. eCollection 2020.
3
Effect of an Adenovirus-Vectored Universal Influenza Virus Vaccine on Pulmonary Pathophysiology in a Mouse Model.腺病毒载体通用流感病毒疫苗对小鼠肺部病理生理学的影响。
J Virol. 2021 Apr 12;95(9). doi: 10.1128/JVI.02359-20.
4
Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens.CpG-ODN 负载的中空聚合物纳米颗粒诱导抗病毒和疫苗应用中的鸡体产生强大免疫反应。
Int J Nanomedicine. 2020 May 11;15:3303-3318. doi: 10.2147/IJN.S241492. eCollection 2020.
5
Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine.氧化锌纳米粒子抑制 H1N1 流感病毒感染:纳米医学的又一新兴应用。
J Biomed Sci. 2019 Sep 10;26(1):70. doi: 10.1186/s12929-019-0563-4.
6
Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.2008年日中药物研发与治疗联合医学研讨会:亚洲制药研究人员合作的必要性。
Drug Discov Ther. 2008 Oct;2(5):262-3.
7
Universal influenza vaccines: from viruses to nanoparticles.通用流感疫苗:从病毒到纳米颗粒。
Expert Rev Vaccines. 2018 Nov;17(11):967-976. doi: 10.1080/14760584.2018.1541408. Epub 2018 Nov 2.
8
Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.纳米技术与免疫工程:纳米技术如何增强 CAR-T 疗法
Acta Biomater. 2020 Jun;109:21-36. doi: 10.1016/j.actbio.2020.04.015. Epub 2020 Apr 13.
9
Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control.纳米技术在针对病原体和宿主的抗病毒递送上的进展:用于大流行控制的多管齐下的治疗干预。
Drug Deliv Transl Res. 2021 Aug;11(4):1420-1437. doi: 10.1007/s13346-021-00965-y. Epub 2021 Mar 21.
10
Prophylaxis and treatment of influenza virus infection.流感病毒感染的预防与治疗。
BioDrugs. 2001;15(5):303-23. doi: 10.2165/00063030-200115050-00003.

引用本文的文献

1
Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment.挖掘针对RNA病毒疾病的抗病毒药物的潜力
Curr Drug Targets. 2025;26(8):534-550. doi: 10.2174/0113894501336800250220051811.
2
Applications of Biomolecular Nanostructures for Anti-Angiogenic Theranostics.生物分子纳米结构在抗血管生成治疗中的应用。
Int J Nanomedicine. 2024 Jun 26;19:6485-6497. doi: 10.2147/IJN.S459928. eCollection 2024.
3
Nanoparticle‑based antiviral strategies to combat the influenza virus (Review).基于纳米颗粒的抗流感病毒策略(综述)

本文引用的文献

1
Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza.联合纳米疫苗在抗流感功效方面显示出协同增强作用。
ACS Biomater Sci Eng. 2016 Mar 14;2(3):368-374. doi: 10.1021/acsbiomaterials.5b00477. Epub 2016 Feb 8.
2
Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness and support robust decision-making and communication.季节性流感疫苗接种效果评估:解释疫苗效力估计并支持有力决策和沟通的框架要素。
Influenza Other Respir Viruses. 2021 Jan;15(1):164-174. doi: 10.1111/irv.12786. Epub 2020 Sep 3.
3
Biomed Rep. 2024 Feb 21;20(4):65. doi: 10.3892/br.2024.1753. eCollection 2024 Apr.
4
Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections.脂质纳米颗粒作为病毒性肺部感染mRNA疫苗的有前景载体
Pharmaceutics. 2023 Apr 3;15(4):1127. doi: 10.3390/pharmaceutics15041127.
5
Sparking Nano-Metals on a Surface of Polyethylene Terephthalate and Its Application: Anti-Coronavirus and Anti-Fogging Properties.在聚对苯二甲酸乙二醇酯表面激发纳米金属及其应用:抗病毒和防雾性能。
Int J Mol Sci. 2022 Sep 11;23(18):10541. doi: 10.3390/ijms231810541.
6
Nanotechnology Applications of Flavonoids for Viral Diseases.黄酮类化合物在病毒疾病中的纳米技术应用
Pharmaceutics. 2021 Nov 8;13(11):1895. doi: 10.3390/pharmaceutics13111895.
7
The Crossroads between Host Copper Metabolism and Influenza Infection.宿主铜代谢与流感感染的交汇点。
Int J Mol Sci. 2021 May 23;22(11):5498. doi: 10.3390/ijms22115498.
8
Silver nanoparticles as a potential treatment against SARS-CoV-2: A review.银纳米粒子作为治疗 SARS-CoV-2 的潜在方法:综述。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1707. doi: 10.1002/wnan.1707. Epub 2021 Feb 27.
The evolution of Tamiflu synthesis, 20 years on: Advent of enabling technologies the last piece of the puzzle?
20年后回顾达菲的合成演变:使能技术的出现是拼图的最后一块吗?
Tetrahedron. 2020 Sep 11;76(37):131440. doi: 10.1016/j.tet.2020.131440. Epub 2020 Jul 26.
4
COVID-19 and Influenza Co-Infection: Report of Three Cases.新型冠状病毒肺炎与流感合并感染:三例报告
Cureus. 2020 Aug 18;12(8):e9852. doi: 10.7759/cureus.9852.
5
Influenza A virus is transmissible via aerosolized fomites.甲型流感病毒可通过气溶胶化的飞沫传播。
Nat Commun. 2020 Aug 18;11(1):4062. doi: 10.1038/s41467-020-17888-w.
6
SARS-CoV-2 pandemic: An overview.2019冠状病毒病大流行概述。
Adv Biol Regul. 2020 Aug;77:100736. doi: 10.1016/j.jbior.2020.100736. Epub 2020 Jun 17.
7
Nanotechnology-based antiviral therapeutics.基于纳米技术的抗病毒疗法。
Drug Deliv Transl Res. 2021 Jun;11(3):748-787. doi: 10.1007/s13346-020-00818-0.
8
High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.伊朗东北部死亡患者中严重急性呼吸综合征冠状病毒 2 型和甲型流感病毒(H1N1)合并感染的高发生率。
J Med Virol. 2021 Feb;93(2):1008-1012. doi: 10.1002/jmv.26364. Epub 2020 Aug 13.
9
A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection.一项分子对接研究将经 FDA 批准的氧化铁纳米颗粒重新用于治疗和控制 COVID-19 感染。
Eur J Pharm Sci. 2020 Oct 1;153:105465. doi: 10.1016/j.ejps.2020.105465. Epub 2020 Jul 12.
10
Coinfection with SARS-CoV-2 and influenza A virus.新型冠状病毒2019(SARS-CoV-2)与甲型流感病毒合并感染。
BMJ Case Rep. 2020 Jul 1;13(7):e236812. doi: 10.1136/bcr-2020-236812.